100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched
₹1,200
Our Recommendation
Doxotero 50mg Injection

88+ trust this
WHO GMP Certified


WHO GMP
Certified

Long Expiry
(>8 Months)

WHO GMP
Certified

Long Expiry
(>8 Months)
Delivery by
In Cancer Adriplus 50 Injection helps to treat certain kinds of cancer. It may be used alone or in combination with other medicines to treat cancer in various parts of the body. Adriplus 50 Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Adriplus 50 Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase II) involved in DNA multiplication of the cancer cells. It also forms harmful chemicals (free radicals) which cause DNA damage. This slows the growth of cancer cells and eventually kills them.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Adriplus 50 Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Adriplus 50 Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Adriplus 50 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Adriplus 50 Injection may cause side effects which could affect your ability to drive. As there is a frequent occurrence of nausea and vomiting with Adriplus 50 Injection so driving should be discouraged.
Safe when prescribed by an expert: Adriplus 50 Injection is safe to use in patients with kidney disease. No dose adjustment of Adriplus 50 Injection is recommended. However, inform your doctor if you have any kidney disease.
Caution Advised: Adriplus 50 Injection should be used with caution in patients with liver disease. Dose adjustment of Adriplus 50 Injection may be needed. Doctor consultation is advised.
G-040 Vikas Centre,106, S.V. Road, Santacruz West Mumbai City Mh 400054 India
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1714-15
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 952
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 431-33
Doxorubicin hydrochloride. Sandwich, Kent: Pfizer Limited; 2009 (25 Jan. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.